Stockreport

Grifols Announces FDA Approval of Xembify®, 20% Subcutaneous Immunoglobulin for Primary Immunodeficiencies

Grifols, S.A. - American Depositary Shares  (GRFS) 
Last grifols, s.a. - american depositary shares earnings: 5/7 07:27 am Check Earnings Report